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Background: Maternal morbidity and mortality in sub-Saharan Africa remains high despite global efforts to reduce
it. In order to lower maternal morbidity and mortality in the immediate term, reduction of delay in the provision of
quality obstetric care is of prime importance. The aim of this study is to assess the occurrence of severe maternal
morbidity and mortality in a rural referral hospital in Tanzania as proposed by the WHO near miss approach and to
assess implementation levels of key evidence-based interventions in women experiencing severe maternal
morbidity and mortality.
Methods: A prospective cross-sectional study was performed from November 2009 until November 2011 in a rural
referral hospital in Tanzania. All maternal near misses and maternal deaths were included. As not all WHO near miss
criteria were applicable, a modification was used to identify cases. Data were collected from medical records using
a structured data abstraction form. Descriptive frequencies were calculated for demographic and clinical variables,
outcome indicators, underlying causes, and process indicators.
Results: In the two-year period there were 216 maternal near misses and 32 maternal deaths. The hospital-based
maternal mortality ratio was 350 maternal deaths per 100,000 live births (95% CI 243–488). The maternal near miss
incidence ratio was 23.6 per 1,000 live births, with an overall case fatality rate of 12.9%. Oxytocin for prevention of
postpartum haemorrhage was used in 96 of 201 women and oxytocin for treatment of postpartum haemorrhage
was used in 38 of 66 women. Furthermore, eclampsia was treated with magnesium sulphate in 87% of all cases.
Seventy-four women underwent caesarean section, of which 25 women did not receive prophylactic antibiotics.
Twenty-eight of 30 women who were admitted with sepsis received parenteral antibiotics. The majority of the
cases with uterine rupture (62%) occurred in the hospital.
Conclusion: Maternal morbidity and mortality remain challenging problems in a rural referral hospital in Tanzania.
Key evidence-based interventions are not implemented in women with severe maternal morbidity and mortality.
Progress can be made through up scaling the use of evidence-based interventions, such as the use of oxytocin for
prevention and treatment of postpartum haemorrhage.
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Despite global efforts through the Safe Motherhood Ini-
tiative and the declaration of the Millennium Develop-
ment Goals (MDG), there is only a slight decline in
maternal mortality in sub-Saharan Africa [1,2]. Although
Tanzania shows progress towards improving maternal
health, as is shown by a 47% decline in maternal mortal-
ity ratio (MMR) between 1990 and 2010 (from an esti-
mated MMR of 870 per 100,000 live births in 1990 to a
MMR of 460 per 100,000 live births in 2010), maternal
mortality remains high [3]. The aim of MDG 5 is to re-
duce maternal mortality by 75% between 1990 and 2015
[4]. Although the numbers of maternal deaths (MD)
around the globe are high, absolute numbers in hospitals
are low. Therefore, including cases of women who al-
most die, but survive pregnancy-related complications,
is progressively being used to study the quality of obstet-
ric care [5-8]. These near miss cases represent most of
the characteristics of maternal deaths [9]. Combined,
they create larger numbers and may lead to more rapid
and precise reporting. Since identification criteria for
near miss cases are not uniform and studies thus not
comparable [6,7], WHO developed a new definition of
maternal near miss (MNM) and identification criteria
for maternal near miss cases in 2009 [10]. This resulted
in the “WHO near miss approach for maternal health”
in 2011 [11].
Currently, in Tanzania half of the deliveries take place
in health facilities and 51% of all deliveries are assisted
by a skilled provider [12]. Unfortunately skilled birth at-
tendance does not necessarily equal good quality of care
[13]. Many evidence-based effective approaches are
available to prevent and treat obstetric emergencies, but
their implementation lags behind [14,15]. Human re-
sources are scarce and policymakers encourage scaling
up facility deliveries. Increased utilization of skilled birth
attendants at facilities with insufficient human resources
may further threaten quality of care. Negative perception
of the quality of care by the community inhibits the de-
cision to deliver in a facility [16,17] and so a vicious cir-
cle is created. When scaling up skilled birth attendance,
there is a need for a well-functioning health system with
sufficient resources and a good infrastructure. Both,
quantity of human resources and quality of care should
be addressed [13,18].
In order to reduce maternal mortality and severe acute
maternal morbidity, it is imperative not only to increase
the numbers of skilled personnel, but also to improve
access to health institutions and to reduce the delay in
providing quality obstetric care within institutions. Qual-
ity of obstetric care can be measured using outcome in-
dicators, such as case fatality rate (CFR), and process
indicators, such as the use of oxytocin after delivery to
prevent postpartum haemorrhage [11,19].This study aims to assess the occurrence of severe ma-
ternal morbidity and mortality in a referral hospital in
rural Tanzania as proposed by the WHO near-miss ap-
proach and to assess implementation levels of key
evidence-based interventions in women experiencing se-
vere maternal morbidity and mortality.
Methods
This study is part of an intervention study. Data that
were collected serve as baseline for an intervention with
simulation-based training in routine delivery care, pre-
vention and treatment of postpartum haemorrhage
(PPH). This was a prospective cross-sectional study,
conducted from November 2009 until November 2011
in Haydom Lutheran Hospital (HLH), a referral hospital
in rural Northern Tanzania. HLH is a 400-bed hospital
owned by the Mbulu Diocese of the Evangelical Lu-
theran Church in Tanzania. The hospital provides free
reproductive and child health services, comprehensive
emergency obstetric care, including ambulance and radio
service. Furthermore there is an Intensive Care Unit
(ICU) with 24-hours medical supervision and mechan-
ical ventilation. Annually there are around 5000 deliver-
ies. Extrapolating from the 2002 census, the immediate
catchment area was covering a population of approxi-
mately 327,000 in 2010 [20]. The greater reference area
covered a population of approximately 2,200,000 people
[20].
Outcome measures
The primary outcome measures were the total number
of MD, MNM and live births (LB) in the hospital during
the study period. Subsequently, outcome indicators were
calculated such as the number of women with life-
threatening conditions. As proposed by the WHO ap-
proach, overall near miss indicators were calculated such
as the severe maternal outcome ratio, the maternal near
miss incidence ratio, the maternal near-miss mortality
ratio, and the case fatality rate. Hospital access indica-
tors were calculated such as the number of women with
life-threatening conditions at arrival, the proportion of
these women among all women with life-threatening
conditions, the proportion of these women coming from
other hospitals, and the women with life-threatening
conditions at arrival mortality index. Lastly, intra hos-
pital care indicators were calculated: the number of ma-
ternal near misses and deaths who developed these
conditions in the hospital and the intra hospital mortal-
ity index.
Implementation levels of evidence-based interventions
were measured, such as use of oxytocin for prevention
and treatment of PPH, use of magnesium sulphate for
treatment of eclampsia, use of prophylactic antibiotics
during caesarean section, use of parenteral antibiotics
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with uterine rupture that occurred in the hospital.
Inclusion criteria
All maternal deaths and maternal near misses that were
admitted to HLH were prospectively included in the
study during the above-mentioned period. A maternal
death is defined as: the death of a woman while pregnant
or within 42 days of termination of pregnancy from any
cause. A maternal near miss is defined as: a woman who
nearly died but survived a complication that occurred
during pregnancy, childbirth or within 42 days of ter-
mination of pregnancy [10]. The intention was to use
the WHO near miss criteria for the identification of ma-
ternal near misses. However, not all WHO criteria were
applicable, and the identification criteria were adapted to
the local situation in HLH as is described elsewhere
[21]. Table 1 shows an overview of the WHO near miss
criteria and the Haydom modification.Data collection
Cases were identified on a daily basis by either the prin-
cipal investigator (EN) or by one of the two trained re-
search assistants (nurse-midwives). This was achieved
through daily participation in the morning report and
daily visits to the maternity ward, ICU and the internal
medicine ward. When the inclusion criteria were met, a
structured data abstraction form was filled out by the
principal investigator or a research assistant. Data were
obtained from the patient record. The facility medical
staff was questioned in case of doubt or missing infor-
mation. General information and obstetric details were
collected. For the hospital access and intra hospital care
indicators, the following information was registered:
health status on arrival, maternal death within 24 hours,
and referral status. For each case, one underlying cause
was identified that started the cascade that led to mater-
nal morbidity or mortality [22]. For example, a primipara
was admitted with obstructed labour and had a caesar-
ean section. After caesarean section she developed sep-
sis. The underlying cause that started the cascade that
led to maternal morbidity or mortality was obstructed
labour. This table shows one diagnosis per woman (mu-
tually exclusive, totally inclusive). For the process indica-
tors, information on preventive measures (measuring of
vital signs, use of oxytocin or other uterotonics for pre-
vention of PPH, use of prophylactic antibiotics during
caesarean section) were registered, as well as the use of
interventions (use of oxytocin or other uterotonics as
treatment for PPH, IV-infusion, blood products, hyster-
ectomy, magnesium sulphate or other anticonvulsant in
case of eclampsia, parenteral therapeutic antibiotics, and
laparotomy for uterine rupture).Quality assessment of the data
The completed data abstraction forms were checked by
a second person on missing data or discrepancies. If
needed, a copy of the hospital file was checked to valid-
ate the recordings. All MD cases were reviewed by a se-
lection of the authors (EN, BEO, JVR and JS), as well as
a random selection of the MNM cases and those cases,
which were difficult to classify into an underlying cause.
Observation bias was addressed by means of auditing all
MD cases and a random sample of the MNM cases by
four authors (EN, BEO, JVR, JS) until consensus was
reached. All data were double entered and cross-checked
in Epidata [23].
Statistical analysis
Data analysis consisted of frequencies of demographic
and clinical variables and underlying causes. Demo-
graphic variables were cross-tabulated for maternal out-
come at discharge, and compared using chi-square test
for categorical variables and t-test for continuous vari-
ables. Outcome indicators were calculated using the
total number of live births during the study period and
the total number of MNM and MD in that same period.
Descriptive frequencies were calculated for underlying
causes and process indicators. All results are reported
as number (n) and frequency (%). Analysis was per-
formed using SPSS Statistics, version 20 (SPSS Inc.
Chicago, Illinois).
Ethical approval
Ethical approval was obtained from the Tanzanian Na-
tional Institute for Medical Research (NIMR) (reference
NIMR/HQ/R.8a/Vol.IX/1247), the Tanzania Commission
for Science and Technology (COSTECH) (reference
2012-56-NA-2011-201), and from the VU university
medical center (VUmc), the Netherlands (reference
2011/389). Data were collected and extracted from pa-
tient records without identification of the subject. Data
abstraction forms were filled in after discharge or death
and therefore study inclusion did not have effect on the
treatment. Considering these precautions, individually
obtained informed consent was not required.
Results
In the two-year study period 248 women with life-
threatening conditions were included at Haydom Lu-
theran Hospital: 216 maternal near miss cases and 32
maternal deaths. In the study period 9471 deliveries and
9136 live births occurred at HLH.
Demographic and clinical characteristics are shown
in Table 2. There were no statistical differences in char-
acteristics between the group of maternal near miss and
the group of maternal deaths. The Datoga tribe, who are
pastoralists, experienced relatively more deaths than
Table 1 WHO near miss criteria adapted to the local context of HLH (reproduced from Nelissen et al.)
WHO near miss criteria Haydom near miss criteria
Clinical criteria
Acute cyanosis Acute cyanosis
Gasping Gasping
Respiratory rate > 40 or < 6/min Respiratory rate > 40 or < 6/min
Shock Shock a
Oliguria non responsive to fluids or diuretics Oliguria non responsive to fluids or diuretics b
Failure to form clots Failure to form clots c
Loss of consciousness lasting > 12 h Loss of consciousness lasting > 12 h d
Cardiac arrest Cardiac arrest e
Stroke Stroke f
Uncontrollable fit/total paralysis Uncontrollable fit/total paralysis g
Jaundice in the presence of pre-eclampsia Jaundice in the presence of pre-eclampsia h
Laboratory-based criteria
Oxygen saturation < 90% for ≥ 60 minutes Oxygen saturation < 90% for ≥ 60 minutes
PaO2/FiO2 < 200 mmHg
Creatinine≥ 300 μmol/l or ≥ 3.5 mg/dL
Bilirubin > 100 μmol/l or > 6.0 mg/dL
pH < 7.1
Lactate > 5 mEq/mL
Acute thrombocytopenia (< 50,000 platelets/ml) Acute thrombocytopenia (< 50,000 platelets/ml)
Loss of consciousness and ketoacids in urine
Management-based criteria
Admission to intensive care unit
Use of continuous vasoactive drugs
Hysterectomy following infection or haemorrhage Hysterectomy following infection or haemorrhage
Transfusion of≥ 5 units of blood Transfusion of≥ 1 unit of blood
Intubation and ventilation for≥ 60 minutes not related to anaesthesia Intubation and ventilation for≥ 60 minutes not related to anaesthesia
Dialysis for acute renal failure
Cardio-pulmonary resuscitation Cardio-pulmonary resuscitation
Severe maternal complications
Eclampsia i
Sepsis or severe systemic infection j
Uterine rupture k
Applicability of the WHO near miss criteria in a low resource setting. PLoS One 2013, 8:e61248.
a: Shock is defined as a persistent severe hypotension, defined as a systolic blood pressure < 90 mmHg for 60 min with a pulse rate of ≥ 120/min despite
aggressive fluid replacement (> 2 L).
b: Oliguria is defined as an urinary output < 30 ml/hour for 4 hours or < 400 ml/24 hr.
c: Failure to form clots is defined as the absence of clotting from the IV site after 7–10 minutes.
d: Unconsciousness/coma lasting > 12 hours is defined as a profound alteration of mental state that involves complete or near-complete lack of responsiveness to
external stimuli or Glasgow Coma Scale < 10.
e: Cardiac arrest is defined as loss of consciousness and absence of pulse or heart beat.
f: Stroke is defined as a neurological deficit of cerebrovascular cause that persists ≥ 24 hours, or is interrupted by death within 24 hours.
g: Uncontrollable fit is a condition in which the brain is in state of continuous seizure.
h: Pre-eclampsia: the presence of hypertension associated with proteinuria. Hypertension is defined as a blood pressure ≥ 140 mmHg (systolic) or ≥ 90 mmHg
(diastolic). Proteinuria is defined as excretion of ≥ 300 mg protein/24 hr or 300 mg protein/litre urine or ≥ 1+ on a dipstick.
i: Eclampsia is defined as the presence of hypertension associated with proteinuria and fits. Hypertension is defined as a blood pressure ≥ 140 mmHg (systolic)
or ≥ 90 mmHg (diastolic). Proteinuria is defined as excretion of ≥ 300 mg protein/24 hr or 300 mg protein/litre urine or ≥ 1+ on a dipstick.
j: Sepsis is defined as a clinical sign of infection and 3 of the following: temp > 38°C or < 36°C, respiration rate > 20/min, pulse rate > 90/min, WBC >12.
k: Uterine rupture is defined as the complete rupture of a uterus (including peritoneum) with (partial) extrusion of the fetus during labour.
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cance. Almost 20% of all near misses (n = 40) and 22% of
all maternal deaths (n = 7) had a gestational age of lessthan 24 weeks on admission. For 42% of all near misses
(n = 91) gestational age was 36 weeks or more, compared
to 25% of all maternal deaths (n = 8). The most common
Table 2 Demographic and clinical characteristics
MNM MD p-value
n = 216 n = 32
Age mean (SD) in years 28.1 (6.3) 29.4
(6.1)
p = 0.266*
< 20 years n (%) 20 (9%) 3 (9%)
20-35 years n (%) 150
(69%)
20 (63%)
≥ 35 years n (%) 46 (21%) 9 (28%)
Marital status
n (%)
p = 0.341***
Single/separated/divorced 21 (10%) 5 (16%)
Married/cohabiting 188
(87%)
25 (78%)
Unknown 7 (3%) 2 (6%)
Tribe n (%) p = 0.477**
Datoga 31 (14%) 7 (22%)
Iraqw 114
(53%)
14 (44%)
Other 61 (28%) 9 (28%)
Unknown 10 (5%) 2 (6%)
Parity n (%) p = 0.742**
0 47 (22%) 5 (16%)
1-2 52 (24%) 7 (22%)
≥ 3 100
(46%)
16 (50%)
Unknown 17 (8%) 4 (13%)
Previous caesarean section n (%) p = 0.307***
No 145
(67%)
24 (75%)
Yes 41 (19%) 3 (9%)
Unknown 30 (14%) 5 (16%)
Gestational age n (%) p = 0.106**
< 24 weeks 40 (19%) 7 (22%)
24-36 weeks 40 (19%) 10 (31%)
≥ 36 weeks 91 (42%) 8 (25%)
Unknown 45 (21%) 7 (22%)
Mode of delivery n (%) ****
Vaginal delivery 80 (37%) 15 (47%)
Caesarean section 69 (32%) 5 (16%)
Laparotomy for uterine rupture 16 (7%) 1 (3%)
Abortion/curettage 22 (10%) 2 (6%)
Laparotomy for ectopic
pregnancy
19 (9%) -
Undelivered 9 (4%) 9 (28%)
Unknown 1 (1%) -
Fetal presentation n (%) ****
Cephalic 110
(51%)
15 (47%)
Breech 10 (5%) 1 (3%)
Other 9 (4%) 1 (3%)
Table 2 Demographic and clinical characteristics
(Continued)
Abortion 40 (19%) 4 (13%)
Unknown 47 (22%) 11 (34%)
* Independent sample t-test; ** Chi-square test; *** Fisher exact test (2-sided);
**** p-value could not be calculated due to too few cases.
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80) and 47% MD (n = 15). This was followed by caesar-
ean section: 32% MNM (n = 69) and 16% MD (n = 5).
There were no assisted vaginal deliveries (e.g. forceps/
vacuum extraction). Almost 30% of all women who died
(n = 9) died undelivered.
As is shown in Table 3, there were 27.1 MNM and
MD per 1,000 live births; this is also referred to as the
severe maternal outcome ratio. For every maternal death
there were 6.8 near miss cases. Hospital-based MMR
was 350 per 100,000 live births (95% CI 243–488), with
an overall CFR of 12.9%. Nearly 70% of all women with
life-threatening conditions were ill on arrival and 20.9%
were referred from another hospital. Death within
24 hours occurred in 7.6% (n = 13) of the women that
were ill on arrival. Seventy-six women (30.6%) developed
a life-threatening condition in the hospital, and four
(5.3%) of these women died as a result of this condition.
Table 4 demonstrates the underlying causes for both
groups (MNM and MD) and the associated CFR per
underlying cause. The major cause of morbidity and
mortality is postpartum haemorrhage, accounting for
27% of all underlying causes, followed by abortion re-
lated complications (17%), obstructed labour (12%), ante
partum haemorrhage (11%), and hypertensive disorders
(9%). Women who got severely ill from an unknown
cause had the highest risk of dying with a CFR of 80%,
followed by cancer (67%) and non-obstetric infectious
diseases (63%).
Process indicators that reflect the use of evidence-
based interventions are presented in Table 5. Two
hundred one women gave birth in the hospital, and 96
(48%) received oxytocin as part of active management of
third stage of labour (AMTSL). Sixty-six women were
diagnosed with severe PPH. Forty-one of these women
(62%) delivered in the hospital and 25 women (38%) de-
livered at home or on their way to the hospital. Twenty-
eight women (42%) who were diagnosed with severe
PPH had received oxytocin routinely after delivery. The
number of women that received oxytocin as treatment
was higher: 38 (58%). Ten women received ergometrine
and/or misoprostol in addition to oxytocin. Fifty-four
women (82%) received intravenous volume replacement,
whereas 61 women (92%) received blood transfusion. In
four women (6%) hysterectomy was performed.
Table 3 Outcome indicators
Outcomes Near-miss
indicators
All live births in the hospital (n) 9136
Severe maternal outcomes
Maternal deaths (n) 32
Maternal near miss cases (n) 216
Women with life-threatening conditions (WLTC) (n) 248
Overall near miss indicators
Severe maternal outcome ratio (SMOR) (per 1,000
live births)
27.1
Maternal near miss incidence ratio (per 1,000 live
births)
23.6
Maternal near miss mortality ratio 6.75
Case fatality rate (%) 12.9%
Hospital access indicators
WLTC at hospital arrival (n) 172
Proportion WLTC at arrival among all WLTC (%) 69.4%
Proportion of WLTC at arrival coming from other
hospitals (%)
20.9%
WLTC at arrival mortality index (%) 7.6%
Intra hospital care indicators
Intra hospital WLTC cases (n) 76
Intra hospital WLTC rate (per 1,000 live births) 8.32
Intra hospital mortality index (%) 5.3%
Live birth (LB): the complete expulsion or extraction from its mother of a
product of conception, irrespective of the duration of the pregnancy, which,
after such separation, breathes or shows any other evidence of life. Each
product of such a birth is considered live born.
Women with life-threatening conditions (WLTC): the sum of maternal near
miss and maternal deaths. (WLTC =MNM +MD).
Severe Maternal Outcome Ratio (SMOR): the number of women with life‐
threatening conditions per 1,000 live births. [SMOR = (MNM +MD)/LB].
MNM incidence ratio: the number of maternal near miss cases per 1,000 live
births. [MNM IR =MNM/LB].
Maternal near miss : mortality ratio: the proportion between maternal near
miss cases and maternal deaths. [MNM : 1 MD].
Case fatality Rate: the number of maternal deaths divided by the number of
women with life-threatening conditions, expressed as a
percentage. [CFR =MD/(MNM +MD)].
WLTC at hospital arrival: the number of women with life‐threatening
conditions who are ill on arrival.
Proportion WLTC at arrival among all WLTC: the number of WLTC who are ill
on arrival divided by the total number of WLTC.
Proportion of WLTC at arrival coming from other hospitals: the number of
WLTC who are ill on arrival and coming from another hospital divided by the
total number of WLTC at arrival.
WLTC at arrival mortality index: the maternal deaths within 24 hours after
arrival (MD24) divided by the number of women with life-threatening
conditions who were ill on arrival, expressed as percentage. [WLTC at arrival
MI = MD24/(WLTC at arrival)].
Intra hospital WLTC cases: the number of women with life-threatening
conditions who developed these life-threatening conditions in the hospital.
Intra hospital WLTC rate (per 1000 live births): the number of women with life-
threatening conditions who developed these life-threatening conditions in the
hospital per 1000 live births.
Intra hospital mortality index: the number of maternal deaths who were not ill
on arrival, divided by the number of women with life-threatening conditions
who were not ill on arrival, expressed as percentage.
Table 4 Underlying causes of maternal morbidity and
mortality (mutually exclusive, totally inclusive)
n (%) CFR (%)*
Indirect Anaemia in pregnancy 19 (8%) 0%
Infectious disease 11 (4%) 63%
Cardiac disease 4 (2%) 50%
Cerebral disease 2 (1%) 50%
Direct Postpartum haemorrhage 67 (27%) 9%
Abortion related complication 43 (17%) 7%
Ante partum haemorrhage 26
(11%)
8%
Hypertensive disorders 21 (9%) 10%
Obstructed labour with uterine rupture 15 (6%) 13%
Obstructed labour without uterine
rupture
15 (6%) 7%
Uterine scar rupture without
obstructed labour
6 (2%) 0%
Puerperal sepsis 9 (4%) 0%
Anaesthesia related complication 1 (0.4%) 0%
Co-
incidental
Cancer 3 (1%) 67%
Trauma 1 (0.4%) 0%
Unknown Unknown/undetermined cause 5 (2%) 80%
* CFR: case fatality rate, calculated as MD/(MD +MNM).
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which 13 women (87%) received magnesium sulphate.
Ten women received diazepam, of which nine alsoreceived magnesium sulphate, indicating that 93%
women received anticonvulsants.
Seventy-four women underwent a caesarean section,
of which 49 (66%) received prophylactic antibiotics.
Twelve women (16%) developed sepsis after caesarean
section and one woman died. Six of the women (50%)
who developed sepsis received prophylactic antibiotics.
Twenty-eight of the women (93%) that were diagnosed
with sepsis received parenteral therapeutic antibiotics.
The last process indicator regarding uterine rupture
revealed that the majority of the ruptures occurred in-
hospital (62%). All women underwent laparotomy, and
one woman died. CFR for uterine rupture was 5%.
Of all women with life-threatening conditions, 227
women (92%) had physical examination on arrival. One
hundred seventy-two women were ill on arrival and 133
(77%) had blood pressure measured, 124 (72%) had pulse
rate taken and of 126 women (73%) temperature was
noted. Saturation was measured in only 10 women (6%).
Full blood count was taken in 155 (90%) of the women
that were ill on arrival.
Discussion
This article presents the results of a prospective cross-
sectional study describing the quality of obstetric care in
a rural referral hospital in Tanzania using the modified
WHO near-miss criteria. It is one of the few studies
Table 5 Process indicators among women with severe
maternal morbidity and mortality
1. Prevention of PPH n (%)
Target population: women who delivered in hospital 201 (100%)
Oxytocin use for AMTSL 96 (48%)
Other uterotonic use for AMTSL 2 (1%)
All uterotonic use for AMTSL 96 (48%)
2. Treatment of PPH
Target population: women with PPH 66 (100%)
Delivery in hospital 41 (62%)
Delivery out hospital 25 (38%)
Oxytocin use (routine) 28 (42%)
Other uterotonic use (routine) -
All uterotonic use (routine) 28 (42%)
Oxytocin use (treatment) 38 (58%)
Other uterotonic use (treatment) 10 (15%)
All uterotonic use (treatment) 39 (59%)
IV-infusion 54 (82%)
Blood products 61 (92%)
Hysterectomy 4 (6%)
CFR 9%
3. Treatment of eclampsia
Target population: women with eclampsia 15 (100%)
Magnesium sulphate use 13 (87%)
Other anticonvulsant use 10 (67%)
Any anticonvulsant use 14 (93%)
CFR 7%
4. Prevention of caesarean section related infection
Target population: women with caesarean section 74 (100%)
Prophylactic antibiotics 49 (66%)
5. Treatment of sepsis
Target population: women with sepsis 30 (100%)
Parenteral therapeutic antibiotics 28 (93%)
CFR 27%
6. Uterine rupture
Target population: women with uterine rupture 21 (100%)
Occurred in hospital 13 (62%)
Occurred out hospital 8 (38%)
Laparotomy 21 (100%)
CFR 5%
PPH: postpartum haemorrhage, this is defined as the loss of 500 ml of blood
or more; AMTSL: active management of third stage of labour; CFR: case fatality
rate, calculated as MD/(MD +MNM).
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[24-28].
MMR in this hospital was 350 maternal deaths per
100,000 live births (95% CI 243–488). Country level
MMR is around 460 per 100,000 live births [3,12]. Pre-
vious studies in the area revealed MMRs of 362 (95%CI 269–456) and 444 (95% CI 371–517) per 100,000
live births in 1995 and 1996 for household and ante-
natal clinic surveys, respectively [25]. It is difficult to
compare the hospital-based calculated MMR with a
population-based MMR because not all women deliver
nor die inside the hospital. Most likely hospital-based
MMR is an overestimation because 48% of the Tanzanian
women deliver at home and 85% of all maternal deaths
are identified in-hospital [12,29]. Having this in mind,
our estimation of MMR is relatively low compared to
the national MMR, as is underlined by previous re-
search from the area. This may be explained by the free
service of the hospital for delivery care and the well-
established transport services. Furthermore, although
the hospital did not have medical specialists, there
were frequent long-term expatriate specialists and vis-
iting specialists from nearby referral hospitals.
A recently published systematic review was con-
ducted that included all studies on maternal near miss
from 2004 until 2010 [7]. It revealed that inclusion cri-
teria used to identify maternal near miss varied widely
and therefore could not easily be compared. The find-
ings showed MNM prevalence rates that varied from
0.04% to 14.98% depending on the different inclusion
criteria that were used. These results were further sub-
divided into regions and the findings from 14 studies
from Africa showed that there is a near-miss preva-
lence rate ranging from 0.05% to 14.98%. The near-
miss prevalence in HLH of 2.48% lies within the lower
range of the studies from Africa that were included in
this analysis. From the fourteen studies that were ana-
lyzed in the sub-group Africa, seven studies used man-
agement specific criteria (emergency hysterectomy or
ICU admission) and had relatively low near-miss rates,
as they did not include all near misses that were admit-
ted to the hospital.
Although maternal mortality and morbidity ratios
are relatively low compared to the rest of the country,
quality of care can still be improved as is shown by the
process indicators. The improvement lies in the up
scaling of evidence-based interventions. As suggested
by Campbell et al. “we should get on with what works”
in order to reduce maternal mortality [28,30]. Imple-
mentation of evidence-based interventions such as
oxytocin use immediately after delivery for prevention
of postpartum haemorrhage can be improved in HLH.
Only 48% of the women received routine oxytocin im-
mediately after delivery, while WHO recommends this
for all women who give birth [31]. WHO also recom-
mends the use of oxytocin for the treatment of PPH
[32], however in HLH it was used in 58% of the cases
with severe PPH. PPH was the leading cause of mater-
nal morbidity and the second cause for maternal mor-
tality in HLH with a CFR of 9%. Confronting hospital
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several possible reasons. Not recording the use of oxy-
tocin in the hospital file is the main reason, followed
by lack of protocols, shortage of staff, and high staff
turnover resulting in less experienced health care
workers. Supply of oxytocin to the ward is not consid-
ered a constraint. Although there were no official
guidelines in HLH available, local policy was to give
10 IU of oxytocin immediately after birth and it was
also the first drug of choice for the treatment of PPH.
Use of oxytocin for prevention and treatment of PPH
should be scaled up to 100% coverage.
Caesarean section seems to be one of the most
important risk factors for postpartum maternal infec-
tion [33,34]. Prophylactic antibiotics reduces endomet-
ritis and decreases wound infections [35]. At HLH it
was used only in 66% of all women who underwent cae-
sarean section. Twelve women (16%) developed sepsis
after caesarean section and one woman died. Of the
women who developed sepsis, six women (50%) re-
ceived prophylactic antibiotics. Sepsis accounted for 4%
of all maternal morbidities in HLH and the number of
women with sepsis after caesarean section may be re-
duced by this simple precaution. Prophylactic use of
antibiotics during caesarean section should be scaled
up to 100%.
Use of magnesium sulphate in case of severe pre-
eclampsia is recommended as it reduces the risk of
eclampsia with 50% and might reduce maternal mortal-
ity [36,37]. Eclampsia is not very common at HLH re-
garding the incidence of 1.6% per 1,000 deliveries, but it
does account for 6% of all women with life-threatening
conditions. Case fatality rate for eclampsia was 7%.
Nearly 90% of all eclamptic women received magnesium
sulphate. Hypertensive disorders are typically detected
during antenatal care (ANC) visits. ANC coverage in
Tanzania is relatively good: 96% of the pregnant women
visit the ANC once and 43% visit the ANC four times or
more. Most women visit the antenatal clinic 2–3 times.
In Manyara region 68.2% of the women have blood pres-
sure measured during ANC visits [12]. ANC visits are a
good opportunity to detect hypertensive disorders, and
blood pressure should be measured on every occasion.
The majority of uterine ruptures occurred in-hospital
, which reflects serious substandard care. Obstructed
labour was prevalent in 12% of all maternal morbidities
and mortalities. Uterine rupture is one of the medical
emergencies with high maternal and perinatal mortal-
ity as is reflected by the maternal CFR of 5% [38,39].
Other hospital-based studies from low-income coun-
tries have reported case fatality rates ranging from 1 to
13% [40]. Audit can be used to reduce the incidence of
uterine rupture as is shown in Malawi [41]. Some of the
recommendations that were implemented in Malawi afterseveral audit sessions were training of healthcare workers
in order to reduce delay in diagnosing obstructed labour
and delay in treatment and implementation of local guide-
lines for augmentation of labour. Increased supervision
should lead to improved documentation and labour
management.
There were several limitations to this study. First, it is
a single-centre and hospital-based study and therefore
findings may not reflect the situation in other settings or
the population in general. Second, information is gath-
ered from hospital files, therefore data quality depends
on the quality of record keeping. We have tried to rem-
edy this by means of conducting prospective data-
collection. Third, for the collection of maternal near
miss cases we have used modified WHO near miss cri-
teria, as the original WHO near miss criteria were not
applicable in the local context. This has to be taken into
account when interpreting the results from this study, as
there have been more near miss cases collected with the
modified criteria, then would have been with the original
criteria [21].Conclusion
The present study shows that, although the hospital-based
maternal mortality ratio is quite low compared to the
country-level maternal mortality ratio, maternal morbidity
and mortality remain challenging problems in a rural re-
ferral hospital in Tanzania. The WHO near miss criteria
used for identification of near miss cases could not all be
applied in this low-resource setting. Therefore the inclu-
sion criteria were modified for use in Haydom. Results
show that there is a gap between actual and optimal use of
evidence-based interventions in women experiencing se-
vere maternal morbidity and mortality. Improvement in
the quality of obstetric care can be made through up scal-
ing the use of evidence-based interventions.
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